These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Transdermal scopolamine in the prevention of motion sickness at sea. Price NM; Schmitt LG; McGuire J; Shaw JE; Trobough G Clin Pharmacol Ther; 1981 Mar; 29(3):414-9. PubMed ID: 7009021 [TBL] [Abstract][Full Text] [Related]
25. Experimental motion sickness: efficacy of transdermal scopolamine plus ephedrine. Graybiel A; Cramer DB; Wood CD Aviat Space Environ Med; 1981 Jun; 52(6):337-9. PubMed ID: 7259691 [TBL] [Abstract][Full Text] [Related]
26. Histaminergic response to Coriolis stimulation: implication for transdermal scopolamine therapy of motion sickness. Wang ET; Zhou DR; He LH Aviat Space Environ Med; 1992 Jul; 63(7):579-82. PubMed ID: 1616432 [TBL] [Abstract][Full Text] [Related]
27. [What is your diagnosis? Unilateral mydriasis due to rubbing the eye with scopolamine]. Kaeser HE Schweiz Rundsch Med Prax; 1992 Apr; 81(15):455-6. PubMed ID: 1565935 [No Abstract] [Full Text] [Related]
28. Scopolamine patch to prevent seasickness: clinical response vs. plasma concentration in sailors. Gil A; Nachum Z; Dachir S; Chapman S; Levy A; Shupak A; Adir Y; Tal D Aviat Space Environ Med; 2005 Aug; 76(8):766-70. PubMed ID: 16110693 [TBL] [Abstract][Full Text] [Related]
29. Preventing motion sickness. Hodgson T Can Med Assoc J; 1982 Jun; 126(12):1374. PubMed ID: 7083089 [No Abstract] [Full Text] [Related]
30. The effects of TTS-scopolamine, dimenhydrinate, lidocaine, and tocainide on motion sickness, vertigo, and nystagmus. Pyykkö I; Padoan S; Schalén L; Lyttkens L; Magnusson M; Henriksson NG Aviat Space Environ Med; 1985 Aug; 56(8):777-82. PubMed ID: 3929760 [TBL] [Abstract][Full Text] [Related]
32. Unilateral mydriasis due to scopolamine patch. Vasselon P; Weiner L; Rossi-Pujo F; Socha M; Peton P; May I; Demore B; Javelot H Int J Clin Pharm; 2011 Oct; 33(5):737-9. PubMed ID: 21870093 [TBL] [Abstract][Full Text] [Related]
33. The efficacy of low-dose intranasal scopolamine for motion sickness. Simmons RG; Phillips JB; Lojewski RA; Wang Z; Boyd JL; Putcha L Aviat Space Environ Med; 2010 Apr; 81(4):405-12. PubMed ID: 20377145 [TBL] [Abstract][Full Text] [Related]
34. I heard that the adhesive patch you can wear to prevent motion sickness is available again. Why was it taken off the market? Mayo Clin Health Lett; 1998 Mar; 16(3):8. PubMed ID: 9516375 [No Abstract] [Full Text] [Related]
36. Efficacy of transdermal scopolamine against seasickness: a 3-day study at sea. Attias J; Gordon C; Ribak J; Binah O; Rolnick A Aviat Space Environ Med; 1987 Jan; 58(1):60-2. PubMed ID: 3814034 [TBL] [Abstract][Full Text] [Related]
37. Anisocoria after scopolamine transdermal patch contamination: A case report. Joo JH Medicine (Baltimore); 2021 Nov; 100(46):e27887. PubMed ID: 34797334 [TBL] [Abstract][Full Text] [Related]
38. Effects of transcutaneous scopolamine and depth on diver performance. Williams TH; Wilkinson AR; Davis FM; Frampton CM Undersea Biomed Res; 1988 Mar; 15(2):89-98. PubMed ID: 3363755 [TBL] [Abstract][Full Text] [Related]